Motivity Secures $27M to Advance AI-Driven ABA Therapy Solutions

What You Should Know: 

– Motivity, a provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers serving children with autism secures a $27M investment from Five Elms Capital, a prominent software investment firm. 

– The funding will accelerate Motivity’s product innovation, expand its team, and enhance support for ABA providers worldwide.

Global Reach and Strategic Partnership

Today, Motivity serves over 550 organizations across seven countries, enhancing the delivery of high-quality, data-driven care. The partnership with Five Elms Capital represents a significant milestone in Motivity’s growth. After careful consideration, Motivity selected Five Elms for its proven track record in scaling founder-led software companies without compromising product integrity or customer service.

With 38 active portfolio companies and a team of over 75 professionals, Five Elms brings strategic operational expertise and capital investment to support Motivity’s long-term vision. The partnership will focus on accelerating advancements in Motivity’s technology, expanding customer support, and enhancing the company’s ability to serve ABA organizations of all sizes.

Leadership Transition and Continued Innovation

As Motivity enters its next phase of growth, the company’s leadership is evolving to drive future expansion. Founder Rex Jakobovits, PhD, will transition to Chief of Strategy and Innovation, leveraging his expertise to guide the company’s long-term vision and technological direction.

Joining the team as CEO is Smith Anderson, previously an Operator with Five Elms Capital, who brings extensive experience in scaling technology companies. This strategic leadership transition ensures a blend of innovative vision and operational expertise.

Motivity’s existing team will remain intact, ensuring operational continuity and maintaining the momentum of the platform’s ongoing development. The company will expand its research and development efforts, focusing on:

• AI-driven insights: Enhancing data analysis and providing actionable intelligence.
• Advanced clinical decision-support tools: Empowering clinicians with data-driven decision-making.
• Solutions to strengthen caregiver engagement: Fostering collaboration and improving patient outcomes.
• Enhanced enterprise capabilities: Meeting the evolving needs of larger ABA organizations.

“This investment isn’t just about scaling; it’s about pushing the boundaries of what’s possible in ABA technology,” said Rex Jakobovits, Founder of Motivity. “Our focus remains the same: delivering intuitive, intelligent solutions that help providers focus on what matters most – improving the lives of children with autism and their families. We couldn’t have gotten here without SBIR funding from the National Institute of Mental Health and the support of its business development programs, including the NIH Entrepreneur in Residence consultation and the NIH Company Showcase Program. With Five Elms’ partnership, we can accelerate our capacity to innovate and expand our impact.”

Motivity Background

Since its founding in 2012, Motivity has been dedicated to empowering ABA clinicians with cutting-edge technology that strengthens clinical effectiveness and improves patient outcomes. The company has secured $11M in Small Business Innovative Research (SBIR) grants, which have been instrumental in developing next-generation solutions, including AI-driven workflows, analytics for clinical decision support, and caregiver engagement tools.